NativeMed Review
Best for: sub-$200 promotional compounded GLP-1 pricing
NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299) and compounded tirzepatide at promotional $183/mo (regular $399), plus NAD+ and several non-weight-loss generics. LegitScript certified.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
NativeMed is a solid telehealth option with balanced features and pricing.
NativeMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored NativeMed
Each dimension is scored algorithmically from NativeMed’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $149/mo, NativeMed runs about 12% below the $170 median for GLP-1 providers.
Effectiveness25%
7.8/10NativeMed offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
5.8/10NativeMed's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.6/10NativeMed provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this NativeMed review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications NativeMed offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides NativeMed offers
Beyond GLP-1s, NativeMed also offers these peptides — tap any for our evidence-based guide.
Pricing
Ready to get started?
Plans and promotions change often — check NativeMed's current pricing and active discounts before you decide.
What we like
- LegitScript Certified (verifiable in the footer)
- Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
- Online questionnaire intake, with a live visit added when state law requires it
Watch-outs
- Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
- States served aren't listed publicly
- Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
NativeMed: a Miami cash-pay shop built around one promotional price
NativeMed (nativemed.net) is a small, cash-pay telehealth provider run by NativeMed, LLC out of 66 W Flagler St in downtown Miami. Its whole pitch is a low sticker price: compounded semaglutide at $149 a month and compounded tirzepatide at a similarly aggressive promotional rate. That undercuts the category median of $170 and lands well under what you'd pay for brand-name pens. If your only goal is to start a compounded GLP-1 for as little money as possible this month, NativeMed is worth a look. But the price is a sale price, and a few things this provider won't put in writing keep it from being a slam dunk.
How the pricing actually works (read the word 'promotional' carefully)
The headline numbers are sale prices. NativeMed's own pages list a regular rate for compounded semaglutide that's roughly double the promo — close to three hundred dollars a month — and a regular tirzepatide rate around four hundred dollars. So the real question isn't whether $149 is cheap; it's whether that rate survives past your first order or quietly steps up to the regular price later. NativeMed doesn't spell out how long the promotion holds, and that's the single most important thing to confirm before you hand over a card.
What is reassuring: the medication price includes the medication itself and shipping, and NativeMed states there are no separate membership fees. The company also advertises free 48-hour shipping. So the monthly figure you see is closer to your true cost than at providers that bolt on a consult fee or a recurring membership charge on top of the drug.
- Promo rate: $149/mo for compounded semaglutide, with tirzepatide a bit higher.
- Regular rate (after promo): roughly double — near three hundred a month for semaglutide, around four hundred for tirzepatide.
- Included: medication plus free 48-hour shipping, and no membership fee.
- Category median for comparison: $170/mo.
The medications and how they're dispensed
NativeMed sells compounded semaglutide and compounded tirzepatide — the same active ingredients as Wegovy/Ozempic and Zepbound/Mounjaro, but made by a compounding pharmacy rather than the brand manufacturer. Alongside the GLP-1s, the formulary also carries NAD+ and a handful of non-weight-loss generics (sildenafil, tadalafil, trazodone), so this is a general cash-pay telehealth shop, not a GLP-1 specialist.
Intake is mostly asynchronous: you fill out an online medical questionnaire, and a live visit gets added only when your state's law requires one. That keeps things fast and cheap, which is the point. It also means the depth of clinical interaction is lighter than at providers that build in a real synchronous consult for everyone.
What sets it apart — and the gap that holds it back
Two things genuinely work in NativeMed's favor. First, it's LegitScript certified, and you can verify that badge yourself in the site footer — a meaningful baseline signal that the pharmacy operation has passed a third-party legitimacy check. Second, there's a named, traceable legal entity behind it: NativeMed, LLC, with a real Miami business address and a separate Florida pharmacy address listed on its Pharmacy Providers page (in Medley, FL). A lot of bargain-priced compounding sites are anonymous; this one isn't.
The gap is transparency about the supply chain. NativeMed describes its pharmacies only as 'USA-based' or 'accredited' rather than naming them, so you can't independently check who is actually compounding your medication or what their accreditation status is. It also doesn't publish the list of states it serves. Neither is a red flag on its own, but for a product you inject into your body, an unnamed pharmacy partner is a real limitation — and the reason our editors hold NativeMed at a MEDIUM verification confidence rather than higher.
Who should choose it — and who should skip it
Choose NativeMed if you're a cost-driven, self-directed patient who wants to start compounded semaglutide or tirzepatide at the lowest possible entry price, you're comfortable with a mostly questionnaire-based intake, and you'll take the time to confirm the promo terms and that they ship to your state.
Skip it if you want a named pharmacy you can vet, brand-name pens (NativeMed only sells compounded), heavy hands-on clinical support, or guaranteed price stability. If those matter more than saving the most up front, a provider that names its pharmacy and posts a flat, non-promotional rate will serve you better. Compare any of these on equal footing using our scoring methodology.
Trust and safety
On the positive side: a confirmed legal entity, a verifiable LegitScript certification, transparent public pricing, and no FDA warning letters or litigation that our team could find as of the April 2026 re-verification. On the cautious side: unnamed pharmacy partners, an unpublished state list, and a price that's explicitly a promotion. That mix is exactly why NativeMed sits in the middle of our trust band — credible enough to consider, with two open questions you should close before enrolling.
Bottom line
NativeMed is one of the cheapest legitimate on-ramps to a compounded GLP-1, anchored by a real Miami company and a LegitScript badge you can check yourself. The asterisks are the promotional pricing and the pharmacy it won't name. Treat the $149 rate as an introductory offer, ask point-blank how long it lasts and which pharmacy fills your script, confirm it ships to your state — and if the answers hold up, it's a defensible budget pick.
Worth pricing against Yucca Health ($146/month) and DudeMeds ($149/month) before you commit — both sit close to NativeMed on cost and formulation.
Ready to start with NativeMed?
Starting at $149/month. See current pricing and start your free consultation.
NativeMed might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to NativeMed
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NativeMed review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with NativeMed?
Starting at $149/month. See current pricing and start your free consultation.